SCHEMBL29904674

SCHEMBL29904674

COc1nc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(N(c2ccc3scnc3c2NS(C)(=O)=O)S(C)(=O)=O)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 12/20 0.50
▸ ROS1 P08922 7/20 0.50
▸ EGFR P00533 9/20 0.47
▸ MET P08581 2/20 0.45
▸ INSR P06213 5/20 0.43
▸ IGF1R P08069 5/20 0.43
▸ BMPR1B O00238 1/20 0.40
▸ PLK4 O00444 1/20 0.40
▸ STK25 O00506 1/20 0.40
▸ RIOK3 O14730 1/20 0.40
▸ CHEK1 O14757 1/20 0.40
▸ CASK O14936 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ GAK O14976 1/20 0.40
▸ DCLK1 O15075 1/20 0.40
▸ MUSK O15146 1/20 0.40
▸ EPHB6 O15197 1/20 0.40
▸ PDPK1 O15530 1/20 0.40
▸ MAP3K13 O43283 1/20 0.40
▸ DAPK3 O43293 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26906727 1.00 ALK (0.50) ALKROS1EGFRMETINSR
SCHEMBL29114860 0.91 ALK (0.47) ALKROS1EGFRMETINSR
SCHEMBL26906899 0.88 EGFR (0.49) ALKEGFRMETINSRIGF1R
SCHEMBL26907013 0.87 ALK (0.52) ALKEGFRMETINSRIGF1R
SCHEMBL26906910 0.85 ALK (0.63) ALKROS1EGFRMETINSR
SCHEMBL29904634 0.85 ALK (0.63) ALKROS1EGFRMETINSR
SCHEMBL29904643 0.83 EGFR (0.42) ALKEGFRMETINSRIGF1R
SCHEMBL26906780 0.83 EGFR (0.42) ALKEGFRMETINSRIGF1R
SCHEMBL29114855 0.83 ALK (0.56) ALKROS1EGFRMETINSR
SCHEMBL26906903 0.82 EGFR (0.44) EGFRJAK2CDK4JAK1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO claimed
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO disclosed
Send feedback